Medipost Accelerates Global Push For Lead Stem Cell Therapy
ASEAN, Japan On Near-Term Radar
South Korean stem cell therapy company Medipost is speeding up the entry of flagship product Cartistem into global markets, with an initial focus on ASEAN countries and Japan and helped by regulators' allowance of early local trials to be waived on the back of strong Korean data.
